A convergent asymmetric synthesis of a growth hormone secretagogue

Tetrahedron Asymmetry

Volumn 14, Issue 22, 2003, Pages 3435-3446

  Zheng, Nan ^a   Armstrong III, Joseph D ^a   Eng, Kan K ^a   Keller, Jennifer ^a   Liu, Tom ^a   Purick, Robert ^a   Lynch, Joseph ^a   Hartner, Frederick W ^a   Volante, R P ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOLACTAM; GROWTH HORMONE SECRETAGOGUE; LACTAM DERIVATIVE; UNCLASSIFIED DRUG; UREA DERIVATIVE;

ALKYLATION; ARTICLE; ASYMMETRIC SYNTHESIS; CHEMICAL MODIFICATION; CHEMICAL REACTION; CRYSTAL STRUCTURE; CRYSTALLIZATION; DRUG SYNTHESIS; IODINATION; PRIORITY JOURNAL; RATING SCALE; STRUCTURE ANALYSIS; SUBSTITUTION REACTION; SUZUKI REACTION; TECHNIQUE;

EID: 0242626791     PISSN: 09574166     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetasy.2003.09.022     Document Type: Article

References (21)

1. Smith R.G., Cheng K., Schoen W.R., Pong S.-S., Hickey G., Jacks T., Butler B., Chan W.W.-S., Chaung L.-Y.P., Judith F., Taylor J., Wyvratt M.J., Fisher M.H. Science. 260:1993;1640-1643. and references cited therein.
2. Schoen, W. R.; Wyvratt, M. J.; Smith, R. G. Annual Reports in Medicinal Chemistry Bristol, J. A., Ed.; Academic Press: California, 1993; Vol. 28, Chapter 19.
3. DeVita R.J., Wyvratt M.J. Drugs of the Future. 21:1996;273-281. and references cited therein.
4. DeVita R.J., Bochis R., Frontier A.J., Kotliar A., Fisher M.H., Schoen W.R., Wyvratt M.J., Cheng K., Chan W.W.-S., Butler B., Jacks T.M., Hickey G.J., Schleim K.D., Leung K., Chen Z., Chiu S.-H.L., Feeney W.P., Cunningham P.K., Smith R.G. J. Med. Chem. 41:1998;1716-1728.
5. Armstrong J.D. III, Eng K.K., Keller J.L., Purick R.M., Hartner F.W. Jr., Choi W.-B, Askin D., Volante R.P. Tetrahedron Lett. 35:1994;3239-3242.
6. King A.O., Anderson R.K., Shuman R.F., Karady S., Abramson N.L., Douglas A.W. J. Org. Chem. 58:1993;3384-3386.
7. Presented at the IBS conference, Peptidomimetics and Small Molecule Design: Accelerating Drug Discovery and Development, Philadelphia, PA, March 10-12, 1997. The edited and updated transcript from this conference was published by IBC in November, 1997 (IBC Library Series publication #984, pp. 163-170).
8. Other solvents have been demonstrated on the steroidal substrates only.
9. 2 was unsuccessful.
10. Olah G.A., Narang S.C., Gupta B.G.B., Malhotra R. J. Org. Chem. 44:1979;1247-1251.
11. 13C 1D NMR as well as a 2D inverse long range correlation experiments were used to characterize the adduct.
12. 2 may occur simply by an extension of an intramolecular Hofmann-Loffler-Freytag reaction.
13. Schoen W.R., Pisano J.M., Prendergast K., Wyvratt M.J., Fisher M.H., Cheng K., Chan W.W.-S., Butler B., Smith R.G., Ball R.G. J. Med. Chem. 37:1994;897-906 Breaking of the D-pyroglutamic salt of 2 was accomplished by partitioning between THF and NaCl saturated concentrated ammonia. Examination of the THF extract by Dionex ion chromatography showed only traces (< 10 ppm) of pyroglutamic acid.
14. Suzuki A. Pure Appl. Chem. 57:1985;1749-1758.
15. Smith G.B., Dezeny G.C., Hughes D.L., King A.O., Verhoeven T.R. J. Org. Chem. 59:1994;8151-8156.
16. For the preparation of (2-formylphenyl)boronic acid, see: Wytko J.A., Graf E., Weiss J. J. Org. Chem. 57:1992;1015-1018.
17. Abdel-Magid A.F., Carson K.G., Harris B.D., Maryanoff C.A., Shah R.D. J. Org. Chem. 61:1996;3849-3862.
18. The structures of dibenzyl amine and tribenzyl amine are: Apparently the reaction of the primary imine with the mono or dibenzyl amine occurred faster than the reduction of the primary imine.
19. Jackson A.H., MacDonald S.F. Can. J. Chem. 35:1957;715-722.
20. Armstrong J.D. III, Wolfe C.N., Keller J.L., Lynch J., Bhupathy M., Volante R.P., DeVita R.J. Tetrahedron Lett. 38:1997;1531-1532.
21. For bulk drug products, no more than 10 ppm of any heavy metal may be present in the final product.